Comparison of delivery strategies for pharmacogenetic testing services.

Published

Journal Article (Review)

The number and use of pharmacogenetic tests to assess a patient's likelihood of response or risk of an adverse event is expanding across medical specialties and becoming more prevalent. During this period of development and translation, different approaches are being investigated to optimize delivery of pharmacogenetic services. In this paper, we review pre-emptive and point-of-care delivery approaches currently implemented or being investigated and discuss the advantages and disadvantages of each approach. The continued growth in knowledge about the genetic basis of drug response combined with development of new and less expensive testing technologies and electronic medical records will impact future delivery systems. Regardless of delivery approach, the currently limited knowledge of health professionals about genetics generally or PGx specifically will remain a major obstacle to utilization.

Full Text

Duke Authors

Cited Authors

  • Haga, SB; Moaddeb, J

Published Date

  • March 2014

Published In

Volume / Issue

  • 24 / 3

Start / End Page

  • 139 - 145

PubMed ID

  • 24384556

Pubmed Central ID

  • 24384556

Electronic International Standard Serial Number (EISSN)

  • 1744-6880

Digital Object Identifier (DOI)

  • 10.1097/FPC.0000000000000028

Language

  • eng

Conference Location

  • United States